Huaren Pharmaceutical Co., Ltd.

Huaren Pharmaceutical Co., Ltd.verified

300110.SZ

Price:

$3.53

Market Cap:

$4.17B

Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. The company offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. It also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and carbohydrate metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable s...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2010-08-25

Stock Exchange

SHZ

Ticker

300110.SZ

The Enterprise Value as of December 2025 (TTM) for Huaren Pharmaceutical Co., Ltd. (300110.SZ) is 5.39B

According to Huaren Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.39B. This represents a change of 14.97% compared to the average of 4.69B of the last 4 quarters.

Huaren Pharmaceutical Co., Ltd. (300110.SZ) Historical Enterprise Value (quarterly & annually)

How has 300110.SZ Enterprise Value performed in the past?

The mean historical Enterprise Value of Huaren Pharmaceutical Co., Ltd. over the last ten years is 7.29B. The current 5.39B Enterprise Value has changed 7.30% with respect to the historical average. Over the past ten years (40 quarters), 300110.SZ's Enterprise Value was at its highest in in the December 2017 quarter at 14.45B. The Enterprise Value was at its lowest in in the December 2018 quarter at 3.87B.

Quarterly (TTM)
Annual

Average

7.29B

Median

6.50B

Minimum

3.74B

Maximum

13.19B

Huaren Pharmaceutical Co., Ltd. (300110.SZ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Huaren Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 80.23%

Maximum Annual Enterprise Value = 13.19B

Minimum Annual Increase = -71.67%

Minimum Annual Enterprise Value = 3.74B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20244.89B-22.30%
20236.29B-6.33%
20226.71B-7.87%
20217.29B23.52%
20205.90B22.61%
20194.81B28.74%
20183.74B-71.67%
201713.19B23.28%
201610.70B14.42%
20159.35B80.23%

Huaren Pharmaceutical Co., Ltd. (300110.SZ) Average Enterprise Value

How has 300110.SZ Enterprise Value performed in the past?

The current Enterprise Value of Huaren Pharmaceutical Co., Ltd. (300110.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.96B

5-year avg

6.22B

10-year avg

7.29B

Huaren Pharmaceutical Co., Ltd. (300110.SZ) Enterprise Value vs. Peers

How is 300110.SZ’s Enterprise Value compared to its peers?

Huaren Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Zhongzhu Healthcare Holding Co.,Ltd (5.24B), less than Honz Pharmaceutical Co., Ltd. (5.52B), greater than Lionco Pharmaceutical Group Co.,Ltd. (3.77B), greater than ZhuZhou QianJin Pharmaceutical Co.,Ltd (4.29B), greater than Nanjing Well Pharmaceutical Group Co.,Ltd. (3.89B), greater than Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (3.44B), greater than Harbin Medisan Pharmaceutical Co., Ltd. (4.90B), less than Henan Taloph Pharmaceutical Stock Co.,Ltd (5.45B), greater than Tibet AIM Pharm. Inc. (3.03B), greater than Jinling Pharmaceutical Company Limited (3.57B),

Build a custom stock screener for Huaren Pharmaceutical Co., Ltd. (300110.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Huaren Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Huaren Pharmaceutical Co., Ltd. (300110.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Huaren Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Huaren Pharmaceutical Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Huaren Pharmaceutical Co., Ltd. (300110.SZ)?

What is the 3-year average Enterprise Value for Huaren Pharmaceutical Co., Ltd. (300110.SZ)?

What is the 5-year average Enterprise Value for Huaren Pharmaceutical Co., Ltd. (300110.SZ)?

How does the current Enterprise Value for Huaren Pharmaceutical Co., Ltd. (300110.SZ) compare to its historical average?